Pear Therapeutics- Warrants (01/12/2026) Total Liabilities

As of the most recent data (December 2022), PEARW shows a total liabilities of $65M. That compares with $110M in the prior-year period — down 39.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEARW's total liabilities is now $65M (was $110M) — a 39.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics- Warrants (01/12/2026) is outperforming or lagging.

Tracking PEARW's total liabilities over time shows whether Pear Therapeutics- Warrants (01/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $65M That compares with $110M in the prior-year period — down 39.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $65M) with ownership activity and broader fundamentals.